UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

1078 - Tumor immune microenvironment drives prognostic relevance correlating with bladder cancer subtypes

European urology supplements : official journal of the European Association of Urology, 2019-03, Vol.18 (1), p.e1455-e1456

2019

Volltextzugriff (PDF)

232 - Performance of FDA/EMA approved PD-L1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab

European urology supplements : official journal of the European Association of Urology, 2019-03, Vol.18 (1), p.e308-e309

2019

Volltextzugriff (PDF)

448 - Cytotoxic T cell related gene expression signature predicts improved outcome in muscle-invasive urothelial bladder cancer patients following radical cystectomy and adjuvant chemotherapy

European urology supplements : official journal of the European Association of Urology, 2019-03, Vol.18 (1), p.e587-e588

2019

Volltextzugriff (PDF)

A0541 - Loss of membranous NECTIN-4 occurs frequently during metastatic spread of urothelial carcinoma and predicts resistance to enfortumab vedotin

European urology, 2023-02, Vol.83, p.S772-S773

2023

Volltextzugriff (PDF)

A1168 - Spatial immunephenotypes of distant metastases but not matched primary urothelial carcinomas predict response to immune checkpoint inhibition

European urology, 2023-02, Vol.83, p.S1686-S1687

2023

Volltextzugriff (PDF)

A1171 - Intrinsic molecular urothelial cancer subtypes remain stable during metastatic evolution

European urology, 2023-02, Vol.83, p.S1690-S1691

2023

Volltextzugriff (PDF)

Adult autopsies during the past decade in Germany : Data from two university hospitals

Der Pathologe, 2017-09, Vol.38 (5), p.430-437

2017

Volltextzugriff (PDF)

c-Met Onkogen bei Nierenzellkarzinomen

Aktuelle Urologie, 2016-12, Vol.47 (6), p.475-479

2016

Volltextzugriff (PDF)

Chromophobe renal cell carcinoma-diagnosis and prognosis

Der Pathologe, 2019-12, Vol.40, p.252-258

Erlmeier, F

2019

Volltextzugriff (PDF)

Chromophobe renal cell carcinoma-diagnosis and prognosis

Der Pathologe, 2019-12, Vol.40 (Suppl 3), p.252

Erlmeier, F

2019

Volltextzugriff (PDF)

Chromophobes Nierenzellkarzinom – Diagnostik und Prognostik

Der Pathologe, 2019-12, Vol.40 (Suppl 3), p.252-258

Erlmeier, F.

2019

Volltextzugriff (PDF)

Cytotoxic T cell related gene expression signature predicts improved outcome in muscle-invasive urothelial bladder cancer patients following radical cystectomy and adjuvant chemotherapy

European urology supplements : official journal of the European Association of Urology, 2019-03, Vol.18 (1), p.e587-e588

2019

Volltextzugriff (PDF)

Erwachsenenobduktionen im letzten Jahrzehnt in Deutschland: Daten zweier Universitätskliniken

Der Pathologe, 2017-09, Vol.38 (5), p.430-437

2017

Volltextzugriff (PDF)

Fetal autopsies : Relic or still a gold standard?

Der Pathologe, 2017-09, Vol.38 (5), p.438-447

2017

Volltextzugriff (PDF)

Fetale Obduktionen: Veraltetes Relikt oder nach wie vor ein Goldstandard?

Der Pathologe, 2017-09, Vol.38 (5), p.438-447

2017

Volltextzugriff (PDF)

Influence of limited examination conditions on contrast-enhanced sonography for characterising liver lesions

Clinical hemorheology and microcirculation, 2019-01, Vol.71 (2), p.267-276

2019

Volltextzugriff (PDF)

Intrinsic molecular urothelial cancer subtypes remain stable during metastatic evolution

European urology, 2023-02, Vol.83, p.S1690-S1691

2023

Volltextzugriff (PDF)

Long-term results following conservative treatment of benign disorders of esophageal passage

Leber, Magen, Darm, 1986-09, Vol.16 (5), p.259

1986

Volltextzugriff (PDF)

Loss of membranous NECTIN-4 occurs frequently during metastatic spread of urothelial carcinoma and predicts resistance to enfortumab vedotin

European urology, 2023-02, Vol.83, p.S772-S773

2023

Volltextzugriff (PDF)

Performance of FDA/EMA approved PD-L1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab

European urology supplements : official journal of the European Association of Urology, 2019-03, Vol.18 (1), p.e308-e309

2019

Volltextzugriff (PDF)

The Role of PD-L1 Expression and Intratumoral Lymphocytes in Response to Perioperative Chemotherapy for Urothelial Carcinoma

Bladder cancer, 2016-10, Vol.2 (4), p.425-432

2016

Volltextzugriff (PDF)

In Situ Metabolomics Expands the Spectrum of Renal Tumours Positive on 99mTc-sestamibi Single Photon Emission Computed Tomography/Computed Tomography Examination

European urology open science (Online), 2020-12, Vol.22, p.88-96

2020

Volltextzugriff (PDF)

Spatial immunephenotypes of distant metastases but not matched primary urothelial carcinomas predict response to immune checkpoint inhibition

European urology, 2023-02, Vol.83, p.S1686-S1687

2023

Volltextzugriff (PDF)

Tumor immune microenvironment drives prognostic relevance correlating with bladder cancer subtypes

European urology supplements : official journal of the European Association of Urology, 2019-03, Vol.18 (1), p.e1455-e1456

2019

Volltextzugriff (PDF)

Über die katalytische wirksamkeit tertiärer amine bei der addition von äthylenoxid an phenol

Die Makromolekulare Chemie, 1966-02, Vol.91 (1), p.231-242

1966

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(11)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(28)

Sprache

Englisch
(17)
Deutsch
(11)

Erscheinungsjahr

n.n

Thema

Pathology
(6)
Life Sciences & Biomedicine
(5)
Science & Technology
(5)
Humans
(4)
Diagnostic Errors
(3)
Medicine
(3)
Medicine & Public Health
(3)
Adult
(2)
Autopsy - Statistics & Numerical Data
(2)
Autopsy - Trends
(2)
Cause Of Death
(2)
Female
(2)
Germany
(2)
Originalien
(2)
Prevalence
(2)
Prognosis
(2)
Quality Control
(2)
Renal Cell Carcinoma
(2)
Stillbirth
(2)
99mtc-Sestamibi Spect/ct
(1)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

1078 - Tumor immune microenvironment drives prognostic relevance correlating with bladder cancer subtypes

232 - Performance of FDA/EMA approved PD-L1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab

448 - Cytotoxic T cell related gene expression signature predicts improved outcome in muscle-invasive urothelial bladder cancer patients following radical cystectomy and adjuvant chemotherapy

A0541 - Loss of membranous NECTIN-4 occurs frequently during metastatic spread of urothelial carcinoma and predicts resistance to enfortumab vedotin

A1168 - Spatial immunephenotypes of distant metastases but not matched primary urothelial carcinomas predict response to immune checkpoint inhibition

A1171 - Intrinsic molecular urothelial cancer subtypes remain stable during metastatic evolution

Adult autopsies during the past decade in Germany : Data from two university hospitals

c-Met Onkogen bei Nierenzellkarzinomen

Chromophobe renal cell carcinoma-diagnosis and prognosis

Chromophobe renal cell carcinoma-diagnosis and prognosis

Chromophobes Nierenzellkarzinom – Diagnostik und Prognostik

Cytotoxic T cell related gene expression signature predicts improved outcome in muscle-invasive urothelial bladder cancer patients following radical cystectomy and adjuvant chemotherapy

Erwachsenenobduktionen im letzten Jahrzehnt in Deutschland: Daten zweier Universitätskliniken

Fetal autopsies : Relic or still a gold standard?

Fetale Obduktionen: Veraltetes Relikt oder nach wie vor ein Goldstandard?

Influence of limited examination conditions on contrast-enhanced sonography for characterising liver lesions

Intrinsic molecular urothelial cancer subtypes remain stable during metastatic evolution

Long-term results following conservative treatment of benign disorders of esophageal passage

Loss of membranous NECTIN-4 occurs frequently during metastatic spread of urothelial carcinoma and predicts resistance to enfortumab vedotin

Performance of FDA/EMA approved PD-L1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab

The Role of PD-L1 Expression and Intratumoral Lymphocytes in Response to Perioperative Chemotherapy for Urothelial Carcinoma

In Situ Metabolomics Expands the Spectrum of Renal Tumours Positive on 99mTc-sestamibi Single Photon Emission Computed Tomography/Computed Tomography Examination

Spatial immunephenotypes of distant metastases but not matched primary urothelial carcinomas predict response to immune checkpoint inhibition

Tumor immune microenvironment drives prognostic relevance correlating with bladder cancer subtypes

Über die katalytische wirksamkeit tertiärer amine bei der addition von äthylenoxid an phenol

Suchergebnisse filtern